Valo Therapeutics Company

Valo Therapeutics is an immunooncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.

Total Funding: 9207932
Headquarters: Helsinki, Southern Finland, Finland
Funding Status: Seed
Employee Number: 11-50
Estimated Revenue: $10M to $50M
Last Funding Type: Debt Financing
Last Funding Date: 2020-02-06
Investors Number: 1
Founded Date: 2016-01-01
Industry: Viral Vectors